CARBOKEM NOVA 150MG INJECTION 15ML
₹796.5*
MRP ₹885
10% off
₹752*
MRP ₹885
15% CB
₹133 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
CARBOKEM NOVA 150MG INJECTION 15ML belongs to a group of anti-cancer medicines used for the treatment of ovarian cancer and small-cell lung cancer. It may sometimes be used to treat other cancers. Cancer forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed). Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
CARBOKEM NOVA 150MG INJECTION 15ML contains 'Carboplatin'. Carboplatin acts by penetrating the cell wall and binding to the cell's DNA, stopping the cell from naturally dividing and functioning, ultimately destroying the cell. These medicines target cancer cells because they often affect rapidly dividing cells.
CARBOKEM NOVA 150MG INJECTION 15ML is prescribed by a doctor experienced in the use of medications to treat cancer. It is administered by a healthcare professional as an injection. You may experience nausea, diarrhoea, vomiting, thrombocytopenia (a low platelet count), peripheral neuropathy (nerves malfunction), nephrotoxicity at high doses and electrolyte disturbances. Most of these side effects of CARBOKEM NOVA 150MG INJECTION 15ML do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.
To treat your condition effectually, continue taking CARBOKEM NOVA 150MG INJECTION 15ML for as long as your doctor has prescribed. Do not stop the CARBOKEM NOVA 150MG INJECTION 15ML midway. Talk to your doctor before taking CARBOKEM NOVA 150MG INJECTION 15ML if you have severe allergic reactions to CARBOKEM NOVA 150MG INJECTION 15ML or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. CARBOKEM NOVA 150MG INJECTION 15ML should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking CARBOKEM NOVA 150MG INJECTION 15ML if you are pregnant or breastfeeding because this CARBOKEM NOVA 150MG INJECTION 15ML can cause harmful effects on the unborn baby. Both women and men using this CARBOKEM NOVA 150MG INJECTION 15ML should use birth control to avoid pregnancy.
CARBOKEM NOVA 150MG INJECTION 15ML contains 'Carboplatin' which belongs to a group of anti-cancer medicines used to treat ovarian cancer and small cell lung cancer. It works by damaging the genetic material (DNA) of the cancer cells, which stops their growth and multiplication. It can be used alone or with other chemotherapy drugs depending on your cancer type.
CARBOKEM NOVA 150MG INJECTION 15ML should be taken under strict medical supervision. The doctor will regularly monitor your condition while taking CARBOKEM NOVA 150MG INJECTION 15ML. To treat your condition effectually, continue taking CARBOKEM NOVA 150MG INJECTION 15ML for as long as your doctor has prescribed. Do not stop the CARBOKEM NOVA 150MG INJECTION 15ML midway. Talk to your doctor before taking CARBOKEM NOVA 150MG INJECTION 15ML if you have severe allergic reactions to CARBOKEM NOVA 150MG INJECTION 15ML or other platinum-containing compounds or if you are suffering from peripheral neuropathy (nerves malfunction), hypotension, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia (a low platelet count), neutropenia (low white blood cell count), tumour lysis syndrome (metabolic abnormalities that can occur as a complication during the treatment of cancer), hepatic disorders. CARBOKEM NOVA 150MG INJECTION 15ML should not be employed in patients with severe bone marrow depression or significant bleeding. Avoid taking CARBOKEM NOVA 150MG INJECTION 15ML if you are pregnant or breastfeeding because this CARBOKEM NOVA 150MG INJECTION 15ML can cause harmful effects on the unborn baby. Both women and men using this CARBOKEM NOVA 150MG INJECTION 15ML should use birth control to avoid pregnancy. Peripheral blood counts should be frequently monitored during CARBOKEM NOVA 150MG INJECTION 15ML treatment and appropriate until recovery is achieved.
Drug-Drug Interactions: CARBOKEM NOVA 150MG INJECTION 15ML interacts with medicines used in the treatment of chemotherapy (e.g. pemetrexed, gemcitabine, pegfilgrastim, paclitaxel, docetaxel), antacid medications (e.g. pantoprazole) and antibiotic medications (e.g. amikacin, gentamicin, kanamycin, streptomycin, tobramycin).
Drug-Food Interactions: No food interaction was found.
Drug-Disease Interactions: Inform your doctor before taking CARBOKEM NOVA 150MG INJECTION 15ML it requires close monitoring if you are suffering from Infection (bacterial/fungal/protozoal/viral), bleeding disorders, bone marrow depression/low blood counts, fever, renal dysfunction or disorders, peripheral neuropathy (nerves malfunction).
Ovarian cancer: Cancer that forms in tissues of the ovary (one of a pair of female reproductive glands in which the ova, or eggs, are formed).
Small-cell lung cancer is a disease in which malignant (cancer) cells form in the tissues of the lung.
Country of origin
Manufacturer/Marketer address
Alcohol
Caution
You are recommended to avoid alcohol consumption while taking CARBOKEM NOVA 150MG INJECTION 15ML. It could lead to avoiding unpleasant side effects.
Pregnancy
Unsafe
CARBOKEM NOVA 150MG INJECTION 15ML should not be used during pregnancy because it causes harm to the fetus (newborn baby). Both women of childbearing potential and men must use an effective contraception method while taking CARBOKEM NOVA 150MG INJECTION 15ML and at least six months afterwards. Please consult your doctor about any concerns regarding this.
Breast Feeding
Unsafe
CARBOKEM NOVA 150MG INJECTION 15ML should not be taken during breastfeeding as it passes into the breastmilk and may harm the nursing baby. It is contraindicated in breastfeeding mothers. Please consult your doctor about any concerns regarding this.
Driving
Caution
CARBOKEM NOVA 150MG INJECTION 15ML may affect your reactions and your ability to drive. Possible side effects of chemotherapy with CARBOKEM NOVA 150MG INJECTION 15ML may occur, such as nausea and vomiting. If you are affected by these side effects, you should not drive and/or operate machines that require you to be alert.
Liver
Caution
If you have had a history or evidence of any liver-related diseases, please consult the doctor before taking CARBOKEM NOVA 150MG INJECTION 15ML. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Kidney
Caution
If you have had a history or evidence of any kidney-related diseases, please consult the doctor before taking CARBOKEM NOVA 150MG INJECTION 15ML. Your doctor will weigh the benefits and any potential risks before prescribing it to you.
Children
Unsafe
Efficacy and safety have not been established. Please consult your doctor. Your doctor will weigh the benefits and potential risks before prescribing them.